Taro Pharmaceutical Industries Net Profit Margin 2006-2019 | TARO

Taro Pharmaceutical Industries net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Taro Pharmaceutical Industries Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-12-31 $0.65B $0.25B 38.15%
2019-09-30 $0.68B $0.27B 40.41%
2019-06-30 $0.68B $0.28B 41.57%
2019-03-31 $0.67B $0.28B 42.09%
2018-12-31 $0.67B $0.31B 46.62%
2018-09-30 $0.64B $0.23B 36.34%
2018-06-30 $0.66B $0.22B 34.05%
2018-03-31 $0.66B $0.21B 31.77%
2017-12-31 $0.68B $0.21B 30.35%
2017-09-30 $0.75B $0.33B 44.04%
2017-06-30 $0.81B $0.40B 49.75%
2017-03-31 $0.88B $0.46B 51.99%
2016-12-31 $0.95B $0.49B 51.58%
2016-09-30 $0.99B $0.54B 54.56%
2016-06-30 $0.97B $0.55B 56.45%
2016-03-31 $0.95B $0.54B 56.95%
2015-12-31 $0.93B $0.58B 62.22%
2015-09-30 $0.91B $0.53B 58.42%
2015-06-30 $0.95B $0.54B 57.07%
2015-03-31 $0.86B $0.48B 55.97%
2014-12-31 $0.81B $0.42B 52.23%
2014-09-30 $0.78B $0.40B 50.51%
2014-06-30 $0.74B $0.35B 47.28%
2014-03-31 $0.76B $0.36B 47.56%
2013-12-31 $0.74B $0.32B 43.42%
2013-09-30 $0.71B $0.29B 41.33%
2013-06-30 $0.67B $0.26B 39.40%
2013-03-31 $0.67B $0.27B 39.64%
2012-12-31 $0.65B $0.26B 40.55%
2012-09-30 $0.61B $0.24B 38.66%
2012-06-30 $0.59B $0.23B 39.15%
2012-03-31 $0.54B $0.20B 37.57%
2011-12-31 $0.51B $0.18B 36.17%
2011-09-30 $0.46B $0.13B 27.17%
2011-06-30 $0.43B $0.09B 20.00%
2011-03-31 $0.41B $0.07B 16.55%
2010-12-31 $0.39B $0.05B 13.27%
2010-09-30 $0.38B $0.06B 15.73%
2010-06-30 $0.37B $0.05B 13.66%
2010-03-31 $0.37B $0.04B 11.78%
2009-09-30 $0.28B $0.04B 14.49%
2009-06-30 $0.27B $0.04B 15.81%
2008-09-30 $0.17B $0.02B 10.65%
2006-03-31 $0.30B $0.01B 1.67%
2005-12-31 $0.30B $0.01B 1.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.613B $0.645B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.421B 36.56
Takeda Pharmaceutical (TAK) Japan $60.753B 10.65
Astellas Pharma (ALPMY) Japan $31.864B 15.92
Eisai (ESALY) Japan $21.826B 40.66
UCB SA (UCBJF) Belgium $17.894B 0.00
Merck (MKGAF) Germany $13.952B 18.30
Grifols, S.A (GRFS) Spain $13.283B 16.51
Catalent (CTLT) United States $11.383B 44.01
Neurocrine Biosciences (NBIX) United States $11.061B 51.12
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.819B 41.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.391B 0.00
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.342B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.273B 10.04
United Therapeutics (UTHR) United States $5.141B 9.74
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.067B 0.00
ChemoCentryx (CCXI) United States $3.905B 0.00
Evotec AG (EVTCY) Germany $3.888B 62.70
Hypermarcas (HYPMY) Brazil $3.658B 11.13
Arrowhead Pharmaceuticals (ARWR) United States $3.427B 374.11
FibroGen (FGEN) United States $3.294B 0.00
PTC Therapeutics (PTCT) United States $3.121B 0.00
Sage Therapeutics (SAGE) United States $1.956B 0.00
Pacira BioSciences (PCRX) United States $1.881B 38.49
Xencor (XNCR) United States $1.834B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.789B 0.00
USANA Health Sciences (USNA) United States $1.778B 18.23
Corcept Therapeutics (CORT) United States $1.736B 17.22
Heron Therapeutics (HRTX) United States $1.722B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.697B 12.99
Zogenix (ZGNX) United States $1.648B 0.00
Akebia Therapeutics (AKBA) United States $1.602B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.584B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.482B 15.97
Portola Pharmaceuticals (PTLA) United States $1.404B 0.00
Karyopharm Therapeutics (KPTI) United States $1.375B 0.00
Indivior (INVVY) United States $1.362B 16.91
Tilray (TLRY) Canada $1.328B 0.00
Translate Bio (TBIO) United States $1.235B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.098B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.014B 45.28
Endo (ENDP) Ireland $0.903B 1.40
ImmunoGen (IMGN) United States $0.848B 0.00
Collegium Pharmaceutical (COLL) United States $0.798B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.777B 0.00
Molecular Templates (MTEM) United States $0.726B 0.00
Aerie Pharmaceuticals (AERI) United States $0.669B 0.00
Ardelyx (ARDX) United States $0.668B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Radius Health (RDUS) United States $0.564B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Harpoon Therapeutics (HARP) United States $0.542B 0.00
DURECT (DRRX) United States $0.510B 0.00
Trillium Therapeutics (TRIL) Canada $0.506B 0.00
Siga Technologies (SIGA) United States $0.498B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 11.07
BioSpecifics Technologies Corp (BSTC) United States $0.449B 17.54
Calithera Biosciences (CALA) United States $0.416B 0.00
Flexion Therapeutics (FLXN) United States $0.398B 0.00
Ocular Therapeutix (OCUL) United States $0.369B 0.00
Organogenesis Holdings (ORGO) United States $0.367B 0.00
MEI Pharma (MEIP) United States $0.356B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.351B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 0.00
TherapeuticsMD (TXMD) United States $0.323B 0.00
Lannett Co Inc (LCI) United States $0.309B 6.78
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
Concert Pharmaceuticals (CNCE) United States $0.298B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.280B 0.00
Rafael Holdings (RFL) United States $0.274B 0.00
Redhill Biopharma (RDHL) Israel $0.247B 0.00
OptiNose (OPTN) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
PROFOUND MEDICL (PROF) Canada $0.201B 0.00
VAXART, INC (VXRT) United States $0.195B 0.00
Jounce Therapeutics (JNCE) United States $0.194B 4.62
IMV INC (IMV) Canada $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 24.00
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.182B 0.00
Aquestive Therapeutics (AQST) United States $0.171B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.135B 0.00
PharmAthene (ALT) United States $0.126B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.126B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.117B 0.00
Recro Pharma (REPH) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.108B 0.00
Sundial Growers (SNDL) Canada $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Heat Biologics (HTBX) United States $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
CTI BioPharma (CTIC) United States $0.074B 0.00
Hemispherx BioPharma (AIM) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Onconova Therapeutics (ONTX) United States $0.066B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Nivalis Therapeutics (ALPN) United States $0.065B 0.00
Iterum Therapeutics (ITRM) Ireland $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.73
GTx (ONCT) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.049B 103.82
IsoRay (ISR) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Lipocine (LPCN) United States $0.045B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.034B 6.48
ElectroCore (ECOR) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.028B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00